ALTUVOCT

This brand name is authorized in Austria, Estonia, France, Italy, Lithuania, Romania, Spain.

Active ingredients

The drug ALTUVOCT contains one active pharmaceutical ingredient (API):

1	Efanesoctocog alfa UNII WH7BHQ0RB4 - EFANESOCTOCOG ALFA
	Efanesoctocog alfa or recombinant coagulation Factor VIII Fc-Von Willebrand Factor-XTEN is a recombinant fusion protein that temporarily replaces the missing coagulation Factor VIII needed for effective haemostasis.
	Read more about Efanesoctocog alfa

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B02BD02	Coagulation factor VIII	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	3084230, 3084241, 3084319, 3084320, 3084331, 3084342, 3084353
ES	Centro de información online de medicamentos de la AEMPS	1241824001, 1241824002, 1241824004, 1241824005, 1241824006, 1241824007
FR	Base de données publique des médicaments	60110654, 60495577, 64317020, 66258503, 67263268, 68225911, 68896821
IT	Agenzia del Farmaco	051253019, 051253021, 051253033, 051253045, 051253058, 051253060, 051253072
LT	Valstybinė vaistų kontrolės tarnyba	1100035, 1100036, 1100037, 1100038, 1100039, 1100040, 1100041
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W70515001, W70516001, W70517001, W70518001, W70519001, W70520001, W70521001